These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Development of a (18) F-labeled tetrazine with favorable pharmacokinetics for bioorthogonal PET imaging. Denk C; Svatunek D; Filip T; Wanek T; Lumpi D; Fröhlich J; Kuntner C; Mikula H Angew Chem Int Ed Engl; 2014 Sep; 53(36):9655-9. PubMed ID: 24989029 [TBL] [Abstract][Full Text] [Related]
26. Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation. Mahas A; Neal Stewart C; Mahfouz MM Biotechnol Adv; 2018; 36(1):295-310. PubMed ID: 29197619 [TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms. Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067 [TBL] [Abstract][Full Text] [Related]
28. Miniature CRISPR-Cas12f1-Mediated Single-Nucleotide Microbial Genome Editing Using 3'-Truncated sgRNA. Lee HJ; Kim HJ; Lee SJ CRISPR J; 2023 Feb; 6(1):52-61. PubMed ID: 36576897 [TBL] [Abstract][Full Text] [Related]
29. Tetrazine bioorthogonal chemistry derived Zhao G; Li Z; Zhang R; Zhou L; Zhao H; Jiang H Front Mol Biosci; 2022; 9():1055823. PubMed ID: 36465558 [TBL] [Abstract][Full Text] [Related]
30. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
31. Natural Nucleoside Modifications in Guide RNAs Can Modulate the Activity of the CRISPR-Cas9 System Prokhorova DV; Vokhtantsev IP; Tolstova PO; Zhuravlev ES; Kulishova LM; Zharkov DO; Stepanov GA CRISPR J; 2022 Dec; 5(6):799-812. PubMed ID: 36350691 [TBL] [Abstract][Full Text] [Related]
32. Tetrazine Carbon Nanotubes for Pretargeted In Vivo "Click-to-Release" Bioorthogonal Tumour Imaging. Li H; Conde J; Guerreiro A; Bernardes GJL Angew Chem Int Ed Engl; 2020 Sep; 59(37):16023-16032. PubMed ID: 32558207 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and radiolabeling of a polar [ Bidesi N; Shalgunov V; Battisti UM; Hvass L; Jørgensen JT; Poulie CBM; Jensen AI; Kjaer A; Herth MM J Labelled Comp Radiopharm; 2023 Jan; 66(1):22-30. PubMed ID: 36539610 [TBL] [Abstract][Full Text] [Related]
34. Tetrazine-Mediated Bioorthogonal System for Prodrug Activation, Photothermal Therapy, and Optoacoustic Imaging. Xie X; Li B; Wang J; Zhan C; Huang Y; Zeng F; Wu S ACS Appl Mater Interfaces; 2019 Nov; 11(45):41875-41888. PubMed ID: 31638763 [TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas Systems towards Next-Generation Biosensing. Li Y; Li S; Wang J; Liu G Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914 [TBL] [Abstract][Full Text] [Related]
36. [Advances in the RNA-targeting CRISPR-Cas systems]. Hong T; Luo Q Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1363-1373. PubMed ID: 37154311 [TBL] [Abstract][Full Text] [Related]
37. Click-to-Release from trans-Cyclooctenes: Mechanistic Insights and Expansion of Scope from Established Carbamate to Remarkable Ether Cleavage. Versteegen RM; Ten Hoeve W; Rossin R; de Geus MAR; Janssen HM; Robillard MS Angew Chem Int Ed Engl; 2018 Aug; 57(33):10494-10499. PubMed ID: 29746709 [TBL] [Abstract][Full Text] [Related]
38. Metal-free bioorthogonal click chemistry in cancer theranostics. Wu D; Yang K; Zhang Z; Feng Y; Rao L; Chen X; Yu G Chem Soc Rev; 2022 Feb; 51(4):1336-1376. PubMed ID: 35050284 [TBL] [Abstract][Full Text] [Related]
39. Nucleic acids as templates and catalysts in chemical reactions: target-guided dynamic combinatorial chemistry and Saha P; Panda D; Dash J Chem Soc Rev; 2023 Jul; 52(13):4248-4291. PubMed ID: 37306487 [TBL] [Abstract][Full Text] [Related]
40. Alkene-tetrazine ligation for imaging cellular DNA. Rieder U; Luedtke NW Angew Chem Int Ed Engl; 2014 Aug; 53(35):9168-72. PubMed ID: 24981416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]